NUS and A*STAR sign MoU with pharma com­pa­nies

BioSpectrum (Asia) - - Academic News -

The Agency for Science, Tech­nol­ogy and Re­search (A*STAR; Sin­ga­pore’s lead pub­lic sec­tor agency for eco­nomic ori­ented re­search) and the Na­tional Univer­sity of Sin­ga­pore (NUS) have signed a Me­moran­dum of Un­der­stand­ing (MoU) with lead­ing phar­ma­ceu­ti­cal com­pa­nies Glax­oSmithK­line (GSK), Pfizer, and Merck Sharp & Dohme (MSD) to es­tab­lish the Pharma In­no­va­tion Pro­gramme Sin­ga­pore (PIPS).

The fo­cus ar­eas for PIPS in­clude con­tin­u­ous man­u­fac­tur­ing, bio-catal­y­sis, process an­a­lyt­i­cal tech­nol­ogy, ad­vanced process con­trol, and en­hanced phar­ma­ceu­ti­cal op­er­a­tions. PIPS will bring to­gether Sin­ga­pore’s pub­lic sec­tor re­search ca­pa­bil­i­ties and the do­main ex­per­tise of key play­ers in the Pharma in­dus­try to im­prove and trans­form the man­u­fac­tur­ing op­er­a­tions and tech­nolo­gies of the in­dus­try.

The MoU was signed at the in­au­gu­ral Fu­ture Of Man­u­fac­tur­ing (FoM) Sum­mit. It was or­gan­ised by A*STAR, with sup­port from the Eco­nomic Devel­op­ment Board (EDB) Sin­ga­pore and SPRING Sin­ga­pore. The sum­mit brings to­gether se­nior top ex­ec­u­tives from Multi­na­tional Com­pa­nies (MNCs), Large Lo­cal En­ter­prises (LLEs), se­nior gov­ern­ment of­fi­cials and lead­ing tech­nol­ogy providers to ex­change ideas on adapt­ing and cap­tur­ing op­por­tu­ni­ties in the com­plex and fast evolv­ing man­u­fac­tur­ing land­scape.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.